Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai - 400 063, Maharashtra, INDIA.
Tel. : (91-22) 4324 4324
Fax : (91-22) 4324 4343
Website: www.sunpharma.com
CIN: L24230GJ1993PLC019050
January 25, 2022 | |
National Stock Exchange of India Limited, | BSE Limited, |
Exchange Plaza, 5th Floor, | Market Operations Dept. |
Plot No. C/1, G Block, | P. J. Towers, |
Bandra Kurla Complex, | Dalal Street, |
Bandra (East), Mumbai- 400 051 | Mumbai - 400 001 |
Scrip Symbol: SUNPHARMA | Scrip Code: 524715 |
Dear Sir/Madam, |
Sub: Prior intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
This is to inform you that the Board of Directors of the Company, at its meeting scheduled to be held on Monday, January 31, 2022, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2021-22.
This is for your information and dissemination.
Thanking you,
Yours faithfully,
For Sun Pharmaceutical Industries Limited
(Ashok Bhuta)
Compliance Officer
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Sun Pharmaceutical Industries Ltd. published this content on 25 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2022 09:06:05 UTC.